XOMA Royalty Corp.
NASDAQ:XOMA
| Market Cap (Intraday) | 315.95M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 84.81 |
| 10-Day MA | $26.86 |
| 50-Day MA | $25.50 |
| 200-Day MA | $25.84 |
XOMA Royalty Corp. Stock, NASDAQ:XOMA
2200 Powell Street, Suite 310, Emeryville, California 94608
United States of America
Phone: +1.510.204.7200
Number of Employees: 13
Description
XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.